The Sepsis drugs in development market research report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Sepsis. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Sepsis and features dormant and discontinued products.
GlobalData tracks 171 drugs in development for Sepsis by 151 companies/universities/institutes. The top development phase for Sepsis is preclinical with 103 drugs in that stage. The Sepsis pipeline has 145 drugs in development by companies and 26 by universities/ institutes. Some of the companies in the Sepsis pipeline products market are: Purine Pharmaceuticals, TheraSource and Feinstein Institute for Medical Research.
The key targets in the Sepsis pipeline products market include Lipopolysaccharide (Endotoxin), Toll Like Receptor 4 (hToll or CD284 or TLR4), and Penicillin Binding Protein (PBP).
The key mechanisms of action in the Sepsis pipeline product include Lipopolysaccharide (Endotoxin) Inhibitor with five drugs in Phase II. The Sepsis pipeline products include 17 routes of administration with the top ROA being Intravenous and 23 key molecule types in the Sepsis pipeline products market including Small Molecule, and Synthetic Peptide.
Sepsis overview
Sepsis is an illness in which the body has a severe response to bacteria or other germs. Sepsis occurs when chemicals released into the bloodstream to fight the infection trigger inflammation throughout the body. This response may be called systemic inflammatory response syndrome (SIRS). Symptoms of sepsis include chills, shaking, difficulty breathing, decrease in platelet count, abnormal heart pumping function, and abdominal pain. The predisposing factors include age and weakened immune system. Treatment includes antibiotics and vasopressors.
For a complete picture of Sepsis’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
